Malignant Transformation of Recurrent Benign Phyllodes Tumor: a Case Report and Comprehensive Review of Literature

Overview

Journal Ann Med Surg (Lond)

Publisher Wolters Kluwer

Specialty Medical Education

Date 2024 Dec 9

PMID 39649923

Authors

Abhikanta Khatiwada

Aashish Bastakoti

Sharada Kc

Usha Sharma

Shivali Rao

Affiliations

Soon will be listed here.

Abstract

Introduction: Phyllodes tumors (PTs) of the breast are rare fibroepithelial neoplasms, accounting for less than 1% of all breast tumors. The WHO classifies PTs into benign, borderline, or malignant categories based on histological features. While benign PTs generally have a favorable prognosis, they carry a risk of transformation into malignant variants, particularly in cases of recurrence.

Case Presentation: A 33-year-old female presented with a recurrent benign PT, previously treated with lumpectomy on two occasions. Recent imaging suggested possible malignant transformation, and histopathological examination confirmed a malignant PT.

Discussion: This case highlights the crucial role of imaging in the early detection of malignant transformation in PTs. Surgical management strategies are discussed, with an emphasis on the potential for recurrent benign tumors to progress to malignancy.

Conclusion: Regular imaging and close follow-up are essential for early detection of malignant transformation in recurrent PTs, guiding timely and appropriate surgical intervention.

References

Tan H, Zhang S, Liu H, Peng W, Li R, Gu Y . Imaging findings in phyllodes tumors of the breast. Eur J Radiol. 2011; 81(1):e62-9. DOI: 10.1016/j.ejrad.2011.01.085. View

Zhou Z, Wang C, Yang Z, Yu X, Guo X . Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence. J Thorac Dis. 2017; 8(11):3361-3368. PMC: 5179374. DOI: 10.21037/jtd.2016.11.03. View

Bernstein L, Deapen D, Ross R . The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993; 71(10):3020-4. DOI: 10.1002/1097-0142(19930515)71:10<3020::aid-cncr2820711022>3.0.co;2-g. View

Tavassoli F . Fibroadenoma and cystosarcoma phyllodes of the male breast. Mod Pathol. 1992; 5(2):114-6. View

Yabuuchi H, Soeda H, Matsuo Y, Okafuji T, Eguchi T, Sakai S . Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology. 2006; 241(3):702-9. DOI: 10.1148/radiol.2413051470. View

Sohrabi C, Mathew G, Maria N, Kerwan A, Franchi T, Agha R . The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines. Int J Surg. 2023; 109(5):1136-1140. PMC: 10389401. DOI: 10.1097/JS9.0000000000000373. View

NORRIS H, Taylor H . Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967; 20(12):2090-9. DOI: 10.1002/1097-0142(196712)20:12<2090::aid-cncr2820201206>3.0.co;2-l. View

Kinoshita T, Fukutomi T, Kubochi K . Magnetic resonance imaging of benign phyllodes tumors of the breast. Breast J. 2004; 10(3):232-6. DOI: 10.1111/j.1075-122X.2004.21316.x. View

Singer A, Tresley J, Velazquez-Vega J, Yepes M . Unusual aggressive breast cancer: metastatic malignant phyllodes tumor. J Radiol Case Rep. 2013; 7(2):24-37. PMC: 3661309. DOI: 10.3941/jrcr.v7i2.1430. View

10.

Kersting C, Kuijper A, Schmidt H, Packeisen J, Liedtke C, Tidow N . Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab Invest. 2005; 86(1):54-61. DOI: 10.1038/labinvest.3700358. View

11.

Liberman L, Bonaccio E, Abramson A, Cohen M, Dershaw D . Benign and malignant phyllodes tumors: mammographic and sonographic findings. Radiology. 1996; 198(1):121-4. DOI: 10.1148/radiology.198.1.8539362. View

12.

Lissidini G, Mule A, Santoro A, Papa G, Nicosia L, Cassano E . Malignant phyllodes tumor of the breast: a systematic review. Pathologica. 2022; 114(2):111-120. PMC: 9248247. DOI: 10.32074/1591-951X-754. View

13.

Pezner R, Schultheiss T, Paz I . Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008; 71(3):710-3. DOI: 10.1016/j.ijrobp.2007.10.051. View

14.

Yoo J, Woo O, Kim Y, Cho K, Yong H, Seo B . Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?. Radiographics. 2010; 30(6):1689-702. DOI: 10.1148/rg.306105511. View

15.

Li J, Tsang J, Chen C, Chan S, Cheung S, Wu C . Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features. Ann Surg Oncol. 2019; 26(9):2747-2758. DOI: 10.1245/s10434-019-07445-1. View

16.

Tan P, Thike A, Tan W, Thu M, Busmanis I, Li H . Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2011; 65(1):69-76. DOI: 10.1136/jclinpath-2011-200368. View

17.

Rai L, Gulzar S, Naqi A, Awais G, Siddiqui S . Benign to Malignant, Malignant to Metastatic: Phyllodes Tumor Biology Transformation. Cureus. 2024; 16(6):e62487. PMC: 11251937. DOI: 10.7759/cureus.62487. View

18.

Franceschini G, Dugo D, Masetti R, Palumbo F, DAlba P, Mule A . Surgical treatment and MRI in phyllodes tumors of the breast: our experience and review of the literature. Ann Ital Chir. 2005; 76(2):127-40. View

19.

Abe M, Miyata S, Nishimura S, Iijima K, Makita M, Akiyama F . Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer. 2011; 18(4):268-72. DOI: 10.1007/s12282-009-0185-x. View

20.

Chao X, Chen K, Zeng J, Bi Z, Guo M, Chen Y . Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis. BMC Cancer. 2019; 19(1):372. PMC: 6480723. DOI: 10.1186/s12885-019-5585-5. View